New weapon tested to help antibiotics fight stubborn cystic fibrosis infections
Disease control
Completed
This early-stage study tested a new drug, CMTX-101, designed to help standard inhaled antibiotics work better in adults with cystic fibrosis who have a chronic lung infection called Pseudomonas aeruginosa. The main goal was to check if a single dose given through an IV was safe a…
Phase: PHASE1, PHASE2 • Sponsor: Clarametyx Biosciences, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC